戻る Agenda
A Pharma/CRO Partnership in the Design and Execution of Paperless Clinical Trials from eICF to Database Lock
Session Chair(s)
Jules Mitchel, PHD, MBA
President and CEO
THI Pharma Services, United States
The paperless clinical trial is a paradigm shift that must occur to enable the clinical trial enterprise to embrace the modern era. We will share our experience partnering, planning, and implementing these trials to assure that there is no compromise on patient safety, data integrity, trial efficiencies and regulatory review.
Learning Objective : Describe the elements of the paperless clinical trial and how it differs from paper-based studies; Discuss the paradigm shift and its impact on the clinical trial stakeholders; Identify how to plan and implement the paperless clinical trial.
Speaker(s)
Paperless Clinical Trial
Michelle Eli
Eli Lilly and Company, United States
Clinical Project Management Advisor, Chorus
Paperless Clinical Trial
Thomas Haag
Cardinal Solutions Consuting, LLC, United States
Principal Consultant